RPV is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) and plays a crucial role in inhibiting viral replication in people living with HIV (PLWHIV). Both FTC and TAF belong to the class of nucleoside reverse transcriptase inhibitors (NRTIs).3,4
NNRTIs like RPV exert their therapeutic effects by binding permanently to the reverse transcriptase enzyme of HIV,...